NerveX Neurotechnologies

Private

TorontoHealthcare & Life Scienceshttps://nx.vet/

Last Round

Accelerator

Mar 29, 2021

Total Funding Raised

$10,000

Company Overview

NerveX Neurotechnologies is a healthcare technology company that develops AI-powered veterinary practice management software and medical device technology to streamline clinical workflows and improve animal care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Vertical SaaS, Medical AI, EHR & EMR

Business Model

B2B

Customer Profile

Subscription SaaS, Hardware Sales

AI Layer

Application

Keywords

veterinary practice managementveterinary AIAI scribeclinical documentationmedical transcriptionveterinary softwarevet techdigital stethoscopeSOAP notesneuromodulationSaaSpractice automationmedical deviceswearable technologytelemedicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NerveX Neurotechnologies Comps

Public and private peers based on sector, stage, and business model.

NerveX Neurotechnologies comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

NerveX Neurotechnologies Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Accelerator	Mar 29, 2021
Grant	Mar 16, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Mark de Wolde DVM MRCVS

Co-Founder & Chief Veterinary Officer

Founding Team

Gerard O'Leary

Co-Founder, CEO, CTO

Founding Team

NerveX Neurotechnologies Investors

Notable investors and investment history

NerveX Neurotechnologies investors
Investor	Rounds
University of Toronto Early Stage Technology	Accelerator
TIAP	Accelerator

View all Investors

NerveX Neurotechnologies Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

NerveX Neurotechnologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NerveX Neurotechnologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto

Employee Range5

Year Founded2021

Last FundingMar 29, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.